DASA has announced a conference that will give organisations the chance to submit ideas for regenerative medicine for conflict injury.
The Defence and Security Accelerator (DASA) invites all those with an interest in regenerative medicine, particularly for the treatment of traumatic conflict injury, to a demonstration and discussion event on 6 June 2019. Suppliers funded at Phase 1 of the Regenerative Medicine at the Front Line competition will be showcasing their projects.
There will also be an opportunity to hear plans for a Phase 2 competition, as well as receive an update on the wider regenerative medicine strategy, to see how to get involved. The demonstrations will be led by DASA funded suppliers: Universities of Nottingham, Bristol and Birmingham, and Plasticell Ltd.
Dr Matthias Pumberger from the regenerative medicine programme at Charité, Berlin, will deliver the keynote speech. Charité is one of the largest teaching hospitals in Europe and the regenerative medicine programme brings together experts from the fields of medicine, biology and engineering to deliver novel therapies including in the area of musculoskeletal injury.
DASA has said that they are particularly interested organisation’s attendance at this event if they have an interest in supporting the exploitation of such technologies, or have complementary programmes of work. Representatives from the Defence Science and Technology Laboratory (Dstl) and the Royal Centre for Defence Medicine (RCDM) will be present at the event and welcome discussion on their wider regenerative medicine project, including synergies with other programmes.
If you would like to join our community and read more articles like this then please click here.
The post DASA to hold a conference for conflict injury innovations appeared first on Defence Online.
